1. The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies
- Author
-
Ai-Min Wu, Zhenxuan Shao, Li Tang, Xiang Liu, Xiang Gao, Yong-Long Chi, Qian-Hui Xu, and Qing-Bo Lv
- Subjects
medicine.medical_specialty ,030209 endocrinology & metabolism ,Review ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Prevalence ,medicine ,Humans ,Prospective Studies ,030212 general & internal medicine ,Vitamin D ,Risk factor ,Serum 25 hydroxyvitamin d ,Prospective cohort study ,dose-response ,Hip fracture ,Hip Fractures ,business.industry ,medicine.disease ,Surgery ,meta-analysis ,Increased risk ,serum 25-hydroxyvitamin D ,Oncology ,hip fracture ,Relative risk ,Meta-analysis ,Orthopedic surgery ,business - Abstract
// Qing-Bo Lv 1 , Xiang Gao 1 , Xiang Liu 1 , Zhen-Xuan Shao 1 , Qian-Hui Xu 1 , Li Tang 1 , Yong-Long Chi 1 and Ai-Min Wu 1 1 Department of Orthopedics, Bone Research Institute, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Second Medical School of Wenzhou Medical University, Wenzhou, Zhejiang, China Correspondence to: Ai-Min Wu, email: // Keywords : serum 25-hydroxyvitamin D, hip fracture, meta-analysis, dose-response Received : December 14. 2016 Accepted : February 13, 2017 Published : March 17, 2017 Abstract Hip fracture has increasingly become a social and economic burden. The relationship between serum 25-hydroxyvitamin D levels and the risk of hip fracture reported by previous studies remains controversial. We searched Pubmed and Embase to identify studies reporting the relationship between serum 25-hydroxyvitamin D levels and risk of hip fracture. Fifteen prospective cohort studies with a total of 51239 participants and 3386 hip fracture cases were included. By pooling the Relative Risk of the lowest vs. the highest categories indicated that lower levels of serum 25-hydroxyvitamin D were more likely to be a risk factor for hip fracture with adjusted Relative Risk (95%Confidence Interval) of 1.58 (1.41, 1.77). Subgroup meta-analysis examining the stability of the primary results achieved the same results. A dose-response meta-analysis showed that the risk of hip fracture was a descending curve below the line of RR=1. The descending trend was obvious when serum 25-hydroxyvitamin D levels were less than 60 nmol/L and was flat when serum 25-hydroxyvitamin D levels were more than 60 nmol/L. We found that individuals with low levels of serum 25-hydroxyvitamin D have an increased risk of hip fracture, and this effect was evident when the serum 25-hydroxyvitamin D levels were less than 60 nmol/L.
- Published
- 2017